Biosig Technologies - BSGM Company Cumulative Debt

This daily price chart for Biosig Technologies (BSGM) shows a value of 0.00. Biosig Technologies develops cardiac impulse recording systems, whose sales depend on the modernization of medical centers rather than GDP. Stable profits are driven by the integration of software into heart maps, which creates high customer stickiness. The business operates in an autonomous cycle where the demand for advanced research renders the asset a defensive tool.

For the electrophysiology systems developer Biosig Technologies (BSGM), total financial liabilities reflect the business's dependence on external funding amid operating losses and slow equipment adoption. This metric aggregates short-term and long-term loans, allowing investors to assess the long-term trend of the debt burden and the company's ability to service its debt given the risks of FDA registration delays.